Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study

Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury

(2012) Gerry Van der Mieren et al.   Cardiovascular Diabetology

Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning

(2012) Takayuki Miki et al.   Cardiovascular Diabetology

Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents

(2011) Bruno Rodrigues et al.   Cardiovascular Diabetology

Healing the diabetic heart: Does myocardial preconditioning work?

(2011) Pitchai Balakumar et al.   CELLULAR SIGNALLING

Atorvastatin does not Affect Ischaemia-Induced Phosphatidylserine Exposition in Humans in-vivo

(2011) Constantijn W. Wouters et al.   Journal of Atherosclerosis and Thrombosis

Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study

(2011) Marcus Lind et al.   LANCET

Rosuvastatin Increases Extracellular Adenosine Formation in Humans In Vivo

(2009) Patrick Meijer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Diabetes and survival after coronary artery bypass grafting: comparison with an age- and sex-matched population

(2009) Albert H.M. van Straten et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY